This article is more than 5 years old. Information may no longer be current.
NewYork-Presbyterian/Weill Cornell Medical Center names breast surgery chief
Click Here to Manage Email Alerts
Lisa A. Newman, MD, has been appointed chief of the section of breast surgery at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine.
Newman previously served as surgical oncologist and director of the breast oncology program at Henry Ford Health System.
“Dr. Newman is an exceptionally talented surgical breast oncologist whose clinical and scientific excellence has driven critical advances in the field and has greatly improved the lives of countless patients,” Fabrizio Michelassi, MD, chairman of the department of surgery at Weill Cornell Medicine and surgeon-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, said in a press release. “I am thrilled that she will lead our breast surgery enterprise at Weill Cornell Medicine and NewYork-Presbyterian, where she will ensure that our patients receive exceptional care.”
Newman specializes in skin-sparing and nipple-sparing mastectomies, as well as lymphatic mapping and sentinel lymph node biopsy. She also is recognized for her expertise in neoadjuvant chemotherapy.
Newman is founding medical director for International Center for the Study of Breast Cancer Subtypes, a collaboration between University of Michigan, Henry Ford Health System and Komfo Anokye Teaching Hospital in Ghana. This entity will be headquartered at Weill Cornell Medicine.
Her research interests include the genetics of aggressive breast tumors, as well as how and why breast cancer risk and outcomes vary based on patients’ ethnicity and race.
“[Although] we’ve made wonderful advances in breast cancer, this disease continues to cause far too much pain and suffering,” Newman said in the release. “We are obligated to identify all of the features that account for variation in our ability to detect and control breast cancers.”